|
Re: BETonMACE Placebo Estimate
|
1
|
Resverlogix Corp.
|
Feb 20, 2019 05:44PM
|
|
Re: Contest Tally
|
1
|
Resverlogix Corp.
|
Feb 14, 2019 01:20AM
|
|
Re: NASH is a $35 Billion US/year market
|
1
|
Resverlogix Corp.
|
Dec 31, 2018 07:21PM
|
|
Re: Radio Silence
|
1
|
Resverlogix Corp.
|
Jun 03, 2019 04:27PM
|
|
Re: 3 point MACE vs 5 point MACE
|
1
|
Resverlogix Corp.
|
Nov 02, 2018 06:39PM
|
|
Gilead / Galapagos NV
|
1
|
Resverlogix Corp.
|
Jul 15, 2019 10:45AM
|
|
Recent Libby Pub. /
|
1
|
Resverlogix Corp.
|
Aug 14, 2019 12:16PM
|
|
Re: Potential Market Size
|
1
|
Resverlogix Corp.
|
Apr 18, 2019 12:27PM
|
|
Re: Last hour.....
|
1
|
Resverlogix Corp.
|
May 31, 2019 03:48PM
|
|
Re: DECLARE TIMI-58 w/ prior MI as BETonMACE proxy?
|
1
|
Resverlogix Corp.
|
Mar 29, 2019 11:07AM
|
|
Re: DECLARE TIMI-58 w/ prior MI as BETonMACE proxy?
|
1
|
Resverlogix Corp.
|
Mar 29, 2019 11:34AM
|
|
Re: Beigene
|
1
|
Resverlogix Corp.
|
May 07, 2019 10:07AM
|
|
Re: Reata Nasdaq Symbol RETA
|
1
|
Resverlogix Corp.
|
May 03, 2019 09:57AM
|
|
Re: Reata
|
1
|
Resverlogix Corp.
|
Apr 03, 2019 02:00PM
|
|
Re: Today is opposite day, seeing bid/ask both at $3.06....
|
1
|
Resverlogix Corp.
|
Aug 22, 2019 10:19AM
|
|
10-41 :Cytokine Storm
|
1
|
Resverlogix Corp.
|
Apr 02, 2020 01:50PM
|
|
Re: HDL function is associated with atherosclerotic burden and cardiovascular outcomes in T2D
|
1
|
Resverlogix Corp.
|
Oct 16, 2018 06:57PM
|
|
Re: Biogen/Eisai Scrap Aducanumab
|
1
|
Resverlogix Corp.
|
Mar 25, 2019 10:27AM
|
|
Another Indication ?
|
1
|
Resverlogix Corp.
|
May 11, 2019 10:05AM
|
|
Eastern
|
2
|
Resverlogix Corp.
|
Aug 13, 2019 08:36AM
|
